Uncategorized

Here’s why we are convinced that stocks like Sport Endurance, Inc. (OTC: SENZ) are on the cutting edge of a breakout market.

The numbers are impressive. More than two-thirds of American adults take dietary supplements each year, and according to a new economic impact report funded by the Council for Responsible Nutrition (CRN), the dietary supplement industry contributes $121.6 billion to the U.S. economy (about 0.68% of GDP). It also creates 754,645 jobs nationwide, and pays $38.4 billion in wages, not to mention generous taxes.

These numbers have investors asking how has this market been able to become so large and profitable? The answer lies in lifestyle choices and technology.

Thanks to a new, health-concerned millennial population, the nutritional supplement trend is booming and moving towards wellness and proactive care, especially sports nutrition.

The other major factor is online sales. The millennials are mobile, connected and they have created a whole new paradigm for buying online.

Put these two elements together and you have an extremely lucrative market with the potential for profits rivaled only by the marijuana boom.

We’re focusing on SENZ in the sports nutrition and proactive segment, but take a moment to look at a leader in the nutritional supplement space. Let’s pick an easy target; one that you likely know – Herbalife.

Ok, we get it. This stock has been controversial for different reasons. Mainly because of the way the company structured their sales commissions, but they appear to have cleared that hurdle and are moving on.

Here’s the Thing; Herbalife Ltd. Stock Jumped 14% in May!

Yes, the archetype nutritional supplement provider jumped on a better-than-expected earnings report after it posted a strong first-quarter earnings report. According to data from S&P Global Market Intelligence, the stock finished up 13.5% for the month of May.

As the chart below shows, the gains came following the company’s earnings release at the beginning of the month.

While Herbalife, which is a popular short, will remain a controversial stock, its business looks solid.

Here’s why we like what Herbalife demonstrates:

• They sell nutritional supplements
• The company continues to grow sales dramatically year-over-year
• It uses a direct sales model
• Its stock is now over $72 a share with a market cap of $6.75 billion

There is no denying it: this business model works and has created impressive profits for marketers, distributors and stakeholders in the company.

We’ve identified all the same qualities in SENZ, but it is still in the very early stages of development. For our readers, that means it is still affordable. Their stock is still under $1 a share. How long that will last is questionable as they continue to roll out new products, but it is low-priced right now.

Investors Simply Can’t Believe Just How Profitable These Products Are

It’s no wonder that companies in this space attract a faithful following. The products that they sell are incredibly profitable. They don’t typically require FDA trials or lengthy development and many of them address legitimate health concerns… things like fatigue, depression, decreased libido or sex drive, joint stiffness, aging and other wellness issues.

If you want to make 200%, 600% or as much as 800% on a product, nutritional supplements is one of the few markets where you can guarantee those kinds of returns. Nutritional companies know this and are quick to respond to consumer demand.

SENZ Has the Right Mix Right from The Get Go

Sport Endurance, Inc. develops, markets, and distributes innovative nutritional supplement products throughout the United States. Their primary focus is on three areas of health that most directly impact the lives of most active adults – Total Wellness, Performance, and Recovery.

In the company’s words, “We believe improved health contributes to and promotes a higher quality of life. It’s our goal to improve health by providing quality and effective nutritional supplements.”

While that may sound like a simple mission, it is especially challenging, since these companies live or die by providing products that are big sellers. That’s where we think that SENZ has already got a huge head start.

Sport Endurance has strategically focused on some the biggest money making areas of the nutritional markets: wellness, performance and recovery.

Its initial offering in the Men’s Health category is the natural testosterone booster Ultra Peak T.

The product is designed to help men over thirty overcome decreasing testosterone levels. Low testosterone has been linked to decreased muscle tone, reduced energy levels, and even depression.

Ultra Peak T has a nutrient and ingredient profile supported by the science and endorsed by researchers. It’s considered an excellent supplement for men with low testosterone levels who are looking for an alternative to prescription drugs.

On the purely sports endurance side, SENZ has just released a breakthrough pre-workout drink under the brand name Sports Leg + Lung. The product is a pre-workout drink powder that is designed to boost performance for active adults across a number of athletic activities. Its primary ingredients include a proprietary blend of the patented and clinically-tested performance ingredient, Carnosyn® Beta-alanine, and L-Taurine.

Is it effective? According to the company’s studies, over 90% of the people experienced almost immediate benefits. That’s a big deal in the endurance business.

The products have received early rave reviews and are supported by industry experts who Sport Endurance relies on to endorse their products.

For example, Ultra Peak T is supported by Tavis Piattoly (MS, RD, LDN), who holds the distinction as the Sports Dietitian and Nutrition Consultant for the NFLPA Brain and Body Program at the Tulane Institute of Sports Medicine, Covington Orthopedic, and Fairchild Sports Performance and prior roles as Dietitian for the New Orleans Saints, New Orleans Pelicans, and Tulane University Athletics (2002-2016).

SENZ leverages its relationships with professionals in sports medicine and nutrition to get on top of the leading products.

Nutrition and Sports Nutrition Is Not A Bubble

It’s important not to look at this as a fad. It is not a bubble. The business is huge, extremely profitable and many public companies in the space are killing it.

It’s difficult to estimate the total value of the sports performance market, since there are a large number of crossover products, like infused sport beverages and foods. Let’s just say that it is already a very large piece of the $122 billion nutritional supplements pie – well into the billions.

The leading marketers have obviously caught on and are charging ahead with additives, beverages and supplements. These include Coke (Monster Energy), Pepsi (Gatorade) and Dr. Pepper, who are all on the leading front of this massive, multi-billion-dollar growth trend.

---

FEATURE STOCK: FOR COMPARISON

[table id=7 /]

The Winners: You Missed Out On These, But Still Good to Study

These stocks represent some of the stellar players in the nutrition and supplement market. There is a mix of large, medium and small cap stocks, but they demonstrate how successful this segment has been. They also show clearly just how prolific a company like Sport Endurance, Inc. could become using the right model.

---

[table id=5/]

Our Recommendation: We Give SENZ Our Strong BUY Rating

We see the opportunity for nutritional supplements and sports nutrition as a long and profitable road. There are many paths to go down from beverage enhancements to supplements and food additives. Any of these could be very successful given the right model, products and market strategy.

Our eyes are on the sports and endurance segments, along with the sports beverage market. These are potentially some of the biggest growth areas. Here’s why:

• The population is taking greater responsibility for personal health
• Peoples’ efforts are pointed towards wellness (being proactive through sport)
• Even millennials are looking to better nutritional care for a longer, healthy life
• Individuals are experiencing meaningful results gained from improved nutrition

.. all factors contributing to the massive health and sports nutrition markets where SENZ competes.

Who will be big winners?

Our money is on the innovators who attack the market… bring new ideas… take initiatives…use proven marketing models that have been time-tested by the leaders, like Herbalife and others.

That is the exact profile that we identified in SENZ that makes us give this company strong praise. They are focused, have great products and are supporting their efforts with innovative direct marketing using the latest approaches such as blogs, social media awareness and endorsements.

 

---

---

You Can’t Win the Game Unless You Are In The Game

Remember, you can sit on the sidelines and admire the big gains that the players in this market are enjoying, but to succeed you have to be in the game.

We are bullish on the sports nutrition segment of the nutritional and the supplement sector, but we like the entire business.

If SENZ were able to capture even one percent of the business that Herbalife is bringing through the door, it could be the most profitable healthcare or nutrition stock you will own this year, and for some time to come.

They appear to be moving very quickly on the right path.

USA News Group
Editorial Staff

 

---

---

 

Disclaimer: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. usanewsgroup.com is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Sport Endurance, Inc. advertising and digital media. There may be 3rd parties who may have shares of SENZ, and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. The owner/operator of USA News Group does not own any shares of SENZ.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment

 

Before we get into our in-depth breakdown, let us say that strictly by the numbers, AHPI is a rare find among its peers.

AHPI is trading at around the $2.00 level. The book value is pegged at $4.56 per share, about double the last sale price, with a 12-month Yahoo! Finance Target of $9.02. That’s a 400% increase from recent prices.

It would be impossible to imagine the company being worth less than book value, and easy to see it top the 12-month target.

Importantly, management of AHPI have kept the company debt free. In fact, the company is so liquid, its assets are over three times its debts.

Companies with these unique set of qualities in this position don’t come along every day. We are urging readers to carefully consider that out of the 6500 plus healthcare product companies, there may be less than a dozen publicly traded in this category on the Nasdaq exchange.

Allied Healthcare Products (NASDAQ: AHPI) Is A Leading Under-The-Radar Choice

In the markets, just as in life, it’s easy to get caught up with what’s new, glittery and getting all the attention. The problem is that our fascination with the latest or sexiest thing can leave out some truly great opportunities. It can actually blind investors to real, under-the-radar investments that can produce huge returns.

We’ve identified one of these situations in Allied Healthcare Products, Inc., (NASDAQ: AHPI) a near 70-year old company that we think could make a fortune for investors who take advantage of the current status. Consider it a pure numbers play in a pure healthcare stock.

The View from Ten Thousand Feet

Allied Healthcare Products owns well-established and respected brands in healthcare with a long legacy going back decades. It holds significant assets and a very low share price compared to book value. It also has aged senior management who have significant ownership, but who would likely see a takeover move by a major healthcare player as a great way to both increase shareholder value and take the company boldly into the future.

How that could play out is pure speculation, but AHPI looks like low hanging fruit: it’s ready for the taking.

You won’t likely hear much about Allied Healthcare Products. Not many analysts follow the company or are out there singing its praises, even though it has plenty of institutional and mutual fund investors. The company has no big “buzz” and it’s not listed in every reviewer’s Top 10 Healthcare Stocks list. For our readers, that’s a good thing. Since it’s not widely known, you can currently buy the stock at about $2 a share– something that is nearly unheard of for healthcare companies, especially with established products in growth markets.

We’ve broken down why we think the situation is ripe with opportunity.

The Healthcare Market Is Big, Really Big

Allied Healthcare participates in the massive healthcare market. The US segment alone is worth $150 billion, or roughly 12% of US GDP. It grows faster than virtually anything other sector.

Healthcare is typically a highly profitable business that’s not dependent on economic prosperity and many company’s lead products are often protected from competition by long patent life spans. Most healthcare companies carry huge valuations, a big multiple of growth, massive assets and generally perform well in nearly any market climate.

Allied Healthcare Products competes in the sub-category of Respiratory Care, currently estimated at about $20 billion annually.

According to Global Industry Analysts, Inc., the worldwide market for Respiratory Care Equipment and Supplies is forecast to grow about 3% annually reaching $21+ billion by the year 2020. Of course that could easily double because of factors such as an aging population, the effects of global pollution and a society that insists on being more mobile.

Major growth in this category is being driven by the rising occurrence of major respiratory disorders such as COPE and OSA, growing patient awareness, and access to healthcare infrastructure.

Another segment of respiratory products is emergency respiratory and related emergency medical services (EMS) equipment, which reached an estimated $5.9 billion globally in 2013. At a 2.9% compound annual growth rate (CAGR) from 2013 to 2018, this market is expected to rise to $6.8 billion in 2018.

Allied Healthcare Products Serves the Entire Spectrum

Allied Healthcare Products have developed a full respiratory product offering for hospitals, acute care facilities and nursing homes.

Their core products involve supplying all the plumbing and equipment for hospitals to install “in wall” systems that provide critical support including oxygen, carbon dioxide and other gases used everywhere in a healthcare facility from the OR to the patient’s room. They also sell the valves, regulators and other hardware needed to support these systems.

They have spent almost 70 years developing respect for their brand name products sold under the Chemetron, Schuco, Lif-O-Gen, Timeter, Carbolime, Litholyme and Oxequip labels. And while the public company may not be widely recognized, their products are as familiar to healthcare providers as BAND-AID® adhesive bandages.

More recently, AHPI have introduced mobility systems for home use and a division dedicated to emergency and mass catastrophe conditions. The latest is the Lif-O-Gen A300 an emergency portable oxygen kit. These products service new markets where Allied is able to grow its business beyond traditional respiratory markets.

---

Allied Healthcare Products’ Award Winning Life-O-Gen A300 Portable Respirator Unit

---

Allied Healthcare Products has strong market presence, a broad range of successful products and a huge customer network established over many years – all the right stuff to look for in a successful healthcare products company.

Global Markets Make the Respiratory Care Business More Valuable

The US represents the largest market helped by the aging of the baby boomer population where each day 10,000 people turn 65 years old. The impact of The Affordable Care Act is also providing access to respiratory care for more of the population.

Market growth in Europe is stable, but slower than other regions given that it is generally a stable population. This could change over time based on the flood of immigrants recently streaming into the EU. A long history of government healthcare provided to the masses indicates an existing high level of market penetration.

The Asia-Pacific region is the fastest growing area driven by the massive population base and the many environmental health issues created by rapid industrialization that has depended on coal and other pollutants.

China is evolving into a massive market for respiratory care products that dwarfs the United States. This is a gold mine for companies like Allied Healthcare Products. The evolution of the market is likely to favor companies like AHPI who offer everything from construction level plumbing to hardware applications.

The importance of emerging infectious diseases such as severe acute respiratory syndrome and avian flu infection are big concerns as well as big opportunities. Entering the Asian market would be an instant game changer for AHPI.

Let’s reinforce this very important fact: by the numbers, AHPI looks like a rare find!

AHPI is trading at around the $2.00 level. The book value is pegged at $4.56 per share, about double the last sale price, with a 12-month Yahoo! Finance Target of $9.02. That’s a 400% increase from recent prices.

It would be impossible to imagine the company being worth less than book value, and easy to see it top the 12-month target.

Importantly, management of AHPI have kept the company debt free. In fact, the company is so liquid, its assets are over three times its debts.

Companies with these unique set of qualities in this position don’t come along every day. We are urging readers to carefully consider that out of the 6500 plus healthcare product companies, there may be less than a dozen publicly traded in this category on the Nasdaq exchange.

 

---

FEATURE STOCK: FOR COMPARISON

[table id=4 /]

The Winners: Too Late For Mass Gains, But Good To Study

These stocks represent some of the biggest winners in the healthcare sector over the last several years. These are large cap stocks, but they are evidence of just how well the industry has performed as a whole and offer insight into the kind of mammoth companies who could look to acquire a well positioned company like Allied Health Care Products.

---

[table id=3 /]

Our Recommendation: We Give AHPI Our Strong Buy Rating

It’s easy to be impressed by the latest biotech breakthrough or the potential of a future therapy that saves lives, but let’s face it, many (if not most) of those companies never make it through the complex FDA trials process or ever produce products that reach the market. Check the stats. It’s a fact.

So, while you could be enamored with a promising biotech that just might succeed some 5 to 10 years down the line, you could be solidly positioned with a company that is producing real healthcare products right now; products that are used every day by major medical facilities and care providers across the country. That’s a big difference between AHPI and the group of companies that are banking on future prospects.

Another differentiator is the fact that Allied Healthcare Products have been in business nearly 70 years and have built an installed network with over 3000 hospitals and healthcare facilities. That’s an enormous unseen asset of the company. You can bet the M&A scouts would see it that way.

---

The Respiratory Market is vast and growing worldwide. AHPI is an expert in developing and providing construction systems, in hospital products and now, in-home and portable emergency solutions.

---

We look at this strong business legacy and the current price structure and we see opportunity: opportunity for AHPI to grow its business globally; opportunity for a large healthcare concern to step in and leverage these assets, and opportunity for investors to possibly double, triple or even quadruple their initial stake if these scenarios unfold.

The bottom line is that companies who are invested in mainstream healthcare products and services are now and are expected to continue to be very attractive. That goes for the big winners in our summary (above) and for the small companies with assets, products and a strategic path, like Allied Healthcare Products.

Whether the Trump version of the Healthcare Act includes or excludes millions of covered individuals, the respiratory care segment where AHPI operates will continue to flourish. This could easily be the simple healthcare products company to outperform its superstar counterparts in biotech. That is unless people stop breathing or getting sick.

We like those odds.

USA News Group
Editorial Staff

 

---

---

 

 

 

 

 

 

Disclaimer

This newsletter/advertisement is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA news Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). as of June 6, 2017 MIQ has been compensated a total of twenty-five thousand dollars (CDN) from a third party for Allied Healthcare Products, Inc. (“AHPI”) advertising. This 3rd party may have shares in Allied Healthcare Products, Inc.. and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this report as the basis for any investment decision. The owner/operator of Market IQ Media Group currently owns no shares of AHPI.

Pyramidion Technology Group (OTC: PYTG) Aims To Deliver Infrastructure To Meet Demand

As the old adage goes, timing is everything. And so it goes with the emergence of the cannabis industry – a sector in radical reformation and attracting successful entrepreneurs, leaders in the venture capital community and investors in droves. The business is exploding nationwide, but a question you have to ask yourself is, who or what system or platform is going to distribute and deliver all of the new products to the market? Who will meet this tall order in a timely way and capitalize on the expansion?

We discovered a company that could be possibly one of the best investment opportunities you may come across all year long. Our research reveals that Pyramidion Technology Group Inc. (OTC:PYTG) is so much more than just a simple product and marketing company: this is a logistics powerhouse in the making, planning to offer a whole new infrastructure to the rapid growth cannabis sector. It appears to be just the kind of Amazon-model needed for the new CBD, Cannabis and Hemp marketplace.

A Massive, Growth Market Taking Shape

The US Cannabis market size alone is forecast to represent approximately $44 billion dollars, and according to a recent Washington Post article, it purports that there are up to $120 Billion unaccounted for in what some refer to as “the black market “. If you include adjunct businesses like nutritional supplements and other remedies market (nearly $37 billion dollars), you have what will soon be approximately a $200-billion-dollar market opportunity that didn’t even exist a decade ago.

---

---

How Pyramidion Has Positioned Itself In The Industry “Sweet Spot”

Pyramidion Technology Group is actually a holding company with related, but distinct products, services, markets and opportunities. The company’s focus is on cannabis and hemp related industries in both medicinal and non-medicinal applications.

Their strategy is a simple one: effectively create a complete business solution platform of unlimited opportunities within the cannabis sector. This combines natural relationship marketing synergies and enables the combined companies to provide a wide variety of unique and complete solutions at cost savings to the consumer. These include products, marketing, distribution and fulfillment – and not just for their own products, but for third-party offerings as well.

With A Market This Big A Small Piece Of The Pie Is Huge

Taking the numbers in perspective, it’s easy to see why Pyramidion’s approach could be so lucrative for the company. Even at the low end of scale, the the entire MJ industry is expected to add $20 billion to the U.S. economy by 2018. Pyramidion Technology Group is looking to service just a small, but growing segment of that giant industry with exclusive distribution of CBD and hemp products. So capturing even 1% of the sales and distribution to the U.S. market would represent over $200 million in top line revenue. That in an industry that is experiencing CAGR up to 17% annually through 2020 according to Forbes. Keep in mind, Pyramidion will be one of very few companies with dedicated marketing channels and complete distribution to support this industry.

Pyramidion Is About Building Companies and Infrastructure That Make Them Money

The line of products and services being provided by Pyramidion Technology Group entities represent some of the most potentially profitable sectors of the cannabis and hemp related markets. They include hemp and CBD consumer products, cannabis-based edibles, CBD medications and retail locations, and services supporting the cannabis industry.

The company’s initial group is comprised of the leading brands from established operations including:

Their approach to the business is appears to be unique and from our search, they may be the only company blending technologies designed to

1) generate new consumer cannabis/CBD products

2) provide a marketing channel for products online and at the bricks-and-mortar level

3) offer complete end-to-end fulfillment to this vertical market

What really impressed us most here is how PYTG has invested in multiple lines of revenue for their business spanning products and services, marketing and sales, and distribution. It’s the whole enchilada.

QUESTION – What do you get when you combine cutting-edge technologies, broad distribution networks and diversified revenue streams with the smoking-hot Cannabis, CBD and Hemp products industry?

ANSWER – A multibillion-dollar market opportunity, that, while still is in the early stages, is showing signs of entering into a hyper-growth cycle that will provide outstanding business and investment opportunities.

Here’s a quick look at the state of the cannabis industry. It continues to experience strong growth rates as the industry transitions from being viewed as a gray market and “high risk” into a regulated and legitimate mainstream industry.

Here are 5 simple things to know about the Cannabis medication, medicinal support and CBD market:

1. Legalization – Medical marijuana is now legal in 29 states (Arkansas, Florida and North Dakota passed MMJ laws in the 2016 Election) and Washington D.C. with 8 jurisdictions having passed laws allowing for recreational use (Alaska, Colorado, Oregon, Washington and Washington D.C.).
2. Industry growth – Targeted to be $10 billion by the end of 2015, with $3.1 billion (31%) generated from cannabis sales and the remaining $6.9 Billion (69%) coming from ancillary products and services, with a 30%+ annual growth rate for the years to come, leading to a $44 billion forecasted opportunity.
3. State tax revenue growth – Taxes generated from cannabis sales provide impactful tax revenue dollars to states. For example, in its fiscal year ending June 30, 2015, Colorado generated over $70 Million in tax revenue from medical and recreational marijuana sales. This number is almost double the $42 Million Colorado generated in tax revenue from alcohol sales in the same fiscal year.
4. Boost to the local economy – it is estimated that for every $1 spent on medical and recreational cannabis, there is an infusion of approximately $2.60 to the local economy, which is termed the “marijuana multiplier” effect.
5. Investors are coming – Venture capitalist and PayPal co-founder Peter Thiel’s investment in Privateer Holdings, a cannabis-focused investment fund, is an indicator that sophisticated investors are entering the cannabis industry, which has sparked Wall Street’s attention.

And here 5 major topics for the Cannabis medication and CBD industry going in 2017 (and beyond):

1. On-going legalization – More states will likely legalize cannabis – analysts project that many states are in line to potentially legalize recreational marijuana: Massachusetts; Nevada; California; Maine; Florida, Arkansas and North Dakota all passed legalization laws in the 2016 election.
2. Impact on state tax revenue growth – States that have legalized recreational marijuana use will continue to report the strong tax revenues generated from medical and recreational marijuana sales that will put pressure to lawmakers review their positions.
3. Changing consumer sentiment – It is expected that consumer sentiment will continue to sway and grow in favor of some form of federal legalization of cannabis because of the growing body of information about the medical benefits of cannabis, and the cannabis industry’s economic impact on creating local jobs that cannot be easily transferred to foreign countries.
4. Growth of consumer market – Migration of fragmented, underground consumer market into above-ground, organized market that will be a major catalyst start to attract new cannabis users.
5. Big brands are coming – As the consumer market continues to grow, expect a flood of new lifestyle-branded and celebrity-endorsed cannabis products, e.g. Willie Nelson and Whoopie Goldberg have both recently announced new ventures.

Entrepreneurs have taken notice and are creating business ventures with a specific spin on the cannabis lifestyle.

The cannabis trend is going ballistic and companies like Pyramidion Technology Group Inc. (Stock Quote: PYTG 8.00), are changing the way industry operates. We believe this company could be the next Amazon type model, only in this instance built specifically for the needs of the cannabis sector.

PYTG went public this year and it is now trading on the OTC stock exchange, which makes it one of the very few, publicly listed companies in the booming cannabis sector and likely one of just an elite group intending to provide infrastructure.

If You Build It, They Will Come

Here is how this all comes together… PYTG is perfectly positioned with their business strategy and approach: offer leading products, share marketing synergies, apply cutting-edge technology, and provide broad distribution to internal and third-party products that are not available anywhere else.

This is an infrastructure company in what is likely to be the biggest growth industry over the next 5 to 10 years. It is also one of very, very few companies with the existing networks and capabilities to immediately deliver on demand for the massive expansion.

Importantly, Pyramidion Technologies has not missed out on supplying branded products. Through its own investment in marketing and distribution networks, the company has no less than five investments in eight focused categories with four partners already on the ground offering product. This is important because as the company’s distribution capacity grows, so does the broad awareness and distribution of its own brands. Again, this is a lot like the “sold by Amazon” model that Amazon uses where products are sold by and fulfillment is handled by the company internally – another huge profit multiplier.

You Can Learn From This Stock and Its Legacy

In trying to size up PYTG’s immediate and long term value, think along the lines of what has taken place with Amazon (Nasdaq Ticker: AMZN) starting off selling books, CDs and the like, but now has a market cap of nearly $280 billion.

Pyramidion Technology Group Inc. (OTC: PYTG) is leveraging 21st century technologies, distribution and brand marketing approaches to take advantage of consumers’ unquenchable desire for medicinal and non-medicinal cannabis, CBD and hemp-based products. The sector trend is being transformed into a legitimate, mainstream marketplace and PYTG stands to take advantage of the shift like no other company.

Look for frequent PYTG news announcements from here on out, but we don’t suggest waiting for news before getting on board. It makes sense to get positioned right now. Once the investing public learns what Pyramidion Technology Group is up to, they will likely create a buzz that will make it a favorite topic amongst public cannabis sector investments.

USA News Group
Editorial Staff

Disclaimer

This newsletter/advertisement is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA news Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). as of May 27, 2017 MIQ has been compensated a total of XXX dollars from a third party for Pyramidion Technology Group Inc. advertising. This 3rd party may have shares in Pyramidion Technology Group Inc. and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this report as the basis for any investment decision. The owner/operator of Market IQ Media Group currently owns XXX thousand shares of PYTG which were purchased in the open market and will not be selling these shares in the next 72 hours.